Ginkgo Bioworks Holdings Net Income 2020-2023 | DNA
Ginkgo Bioworks Holdings net income from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Ginkgo Bioworks Holdings Annual Net Income
(Millions of US $) |
| 2022 |
$-2,105 |
| 2021 |
$-1,830 |
| 2020 |
$-127 |
| 2019 |
$-119 |
Ginkgo Bioworks Holdings Quarterly Net Income
(Millions of US $) |
| 2023-03-31 |
$-205 |
| 2022-12-31 |
$-177 |
| 2022-09-30 |
$-669 |
| 2022-06-30 |
$-669 |
| 2022-03-31 |
$-591 |
| 2021-12-31 |
$-1,601 |
| 2021-09-30 |
$-102 |
| 2021-06-30 |
$-54 |
| 2021-03-31 |
$-74 |
| 2020-12-31 |
|
| 2020-09-30 |
$-26 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
